The immunobiology of primary sclerosing cholangitis

Seminars in Immunopathology

Volumn 31, Issue 3, 2009, Pages 383-397

  Aron, Jonathan H ^a   Bowlus, Christopher L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Biliary cirrhosis; Inflammatory bowel disease; Pathogenesis; Primary sclerosing cholangitis

Indexed keywords

1 CHLORO 2,4 DINITROBENZENE; ALPHA4 INTEGRIN; CHEMOKINE; CHEMOKINE RECEPTOR; CYTOKINE; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; INTEGRIN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; LEUKOCYTE ANTIGEN; METRONIDAZOLE; MUCOSAL ADDRESSIN CELL ADHESION MOLECULE 1; MULTIDRUG RESISTANCE PROTEIN 2; N ACETYLLACTOSAMINE SYNTHASE; TETRACYCLINE; VASCULAR ADHESION PROTEIN 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; AUTOIMMUNE DISEASE; COLITIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; ENTERITIS; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; HUMAN; HUMORAL IMMUNITY; ILEITIS; IMMUNOPATHOGENESIS; INFECTION; INNATE IMMUNITY; MOLECULAR TYPING; NONHUMAN; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; REVIEW; SEX RATIO; T LYMPHOCYTE ACTIVATION;

ANIMALS; AUTOIMMUNE DISEASES; BACTERIAL INFECTIONS; CHOLANGITIS, SCLEROSING; CHOLESTASIS; COLITIS; CYTOKINES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNITY, INNATE; MALE; T-LYMPHOCYTE SUBSETS;

EID: 70349569615     PISSN: 18632297     EISSN: 18632300     Source Type: Journal    
DOI: 10.1007/s00281-009-0154-7     Document Type: Review

References (132)

1. R Chapman S Cullen 2008 Etiopathogenesis of primary sclerosing cholangitis World J Gastroenterol 14 3350
2. CA Aoki CL Bowlus ME Gershwin 2005 The immunobiology of primary sclerosing cholangitis Autoimmun Rev 4 137
3. R Saich R Chapman 2008 Primary sclerosing cholangitis, autoimmune hepatitis and overlap syndromes in inflammatory bowel disease World J Gastroenterol 14 331
4. TH Karlsen E Schrumpf KM Boberg 2007 Genetic epidemiology of primary sclerosing cholangitis World J Gastroenterol 13 5421-5431
5. K Bambha WR Kim J Talwalkar H Torgerson JT Benson TM Therneau EV Loftus Jr BP Yawn ER Dickson LJ Melton 3rd 2003 Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community Gastroenterology 125 1364
6. JG Kingham N Kochar MB Gravenor 2004 Incidence, clinical patterns, and outcomes of primary sclerosing cholangitis in South Wales, United Kingdom Gastroenterology 126 1929
7. GG Kaplan KB Laupland D Butzner SJ Urbanski SS Lee 2007 The burden of large and small duct primary sclerosing cholangitis in adults and children: a population-based analysis Am J Gastroenterol 102 1042
8. TR Card M Solaymani-Dodaran J West 2008 Incidence and mortality of primary sclerosing cholangitis in the UK: a population-based cohort study J Hepatol 48 939
9. KJ Hurlburt BJ McMahon H Deubner B Hsu-Trawinski JL Williams KV Kowdley 2002 Prevalence of autoimmune liver disease in Alaska Natives Am J Gastroenterol 97 2402
10. R Kochhar MK Goenka K Das B Nagi DK Bhasin YK Chawla K Vaiphei K Singh JB Dilawari 1996 Primary sclerosing cholangitis: an experience from India J Gastroenterol Hepatol 11 429
11. A Escorsell A Pares J Rodes JA Solis-Herruzo M Miras E de la Morena 1994 Epidemiology of primary sclerosing cholangitis in Spain. Spanish Association for the Study of the Liver J Hepatol 21 787
12. A Shorbagi Y Bayraktar 2008 Primary sclerosing cholangitis-what is the difference between east and west? World J Gastroenterol 14 3974
13. E Schrumpf KM Boberg 2001 Epidemiology of primary sclerosing cholangitis Best Pract Res Clin Gastroenterol 15 553
14. A Tanaka Y Takamori G Toda S Ohnishi H Takikawa 2008 Outcome and prognostic factors of 391 Japanese patients with primary sclerosing cholangitis Liver Int 28 983-989
15. H Takikawa 2007 Characteristics of primary sclerosing cholangitis in Japan Hepatol Res 37 Suppl 3 S470-S473
16. RH Wiesner PM Grambsch ER Dickson J Ludwig RL MacCarty EB Hunter TR Fleming LD Fisher SJ Beaver NF LaRusso 1989 Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis Hepatology 10 430
17. U Broome R Olsson L Loof G Bodemar R Hultcrantz A Danielsson H Prytz H Sandberg-Gertzen S Wallerstedt G Lindberg 1996 Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis Gut 38 610
18. E Schrumpf M Abdelnoor O Fausa K Elgjo E Jenssen F Kolmannskog 1994 Risk factors in primary sclerosing cholangitis J Hepatol 21 1061-1066
19. JM Farrant KM Hayllar ML Wilkinson J Karani BC Portmann D Westaby R Williams 1991 Natural history and prognostic variables in primary sclerosing cholangitis Gastroenterology 100 1710-1717
20. L Okolicsanyi L Fabris S Viaggi N Carulli M Podda G Ricci 1996 Primary sclerosing cholangitis: clinical presentation, natural history and prognostic variables: an Italian multicentre study. The Italian PSC Study Group Eur J Gastroenterol Hepatol 8 685-691
21. H Takikawa Y Takamori A Tanaka H Kurihara Y Nakanuma 2004 Analysis of 388 cases of primary sclerosing cholangitis in Japan; presence of a subgroup without pancreatic involvement in older patients Hepatol Res 29 153
22. TL Ang KM Fock TM Ng EK Teo TS Chua JY Tan 2002 Clinical profile of primary sclerosing cholangitis in Singapore J Gastroenterol Hepatol 17 908
23. EV Loftus Jr GC Harewood CG Loftus WJ Tremaine WS Harmsen AR Zinsmeister DA Jewell WJ Sandborn 2005 PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis Gut 54 91
24. ME Himmel G Hardenberg CA Piccirillo TS Steiner MK Levings 2008 The role of T-regulatory cells and Toll-like receptors in the pathogenesis of human inflammatory bowel disease Immunology 125-145
25. J Hampe A Franke P Rosenstiel A Till M Teuber K Huse M Albrecht G Mayr FM De La Vega J Briggs S Gunther NJ Prescott CM Onnie R Hasler B Sipos UR Folsch T Lengauer M Platzer CG Mathew M Krawczak S Schreiber 2007 A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1 Nat Genet 39 207 (Pubitemid 46184351)
26. Y Ogura DK Bonen N Inohara DL Nicolae FF Chen R Ramos H Britton T Moran R Karaliuskas RH Duerr JP Achkar SR Brant TM Bayless BS Kirschner SB Hanauer G Nunez JH Cho 2001 A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease Nature 411-603
27. JP Hugot M Chamaillard H Zouali S Lesage JP Cezard J Belaiche S Almer C Tysk CA O'Morain M Gassull V Binder Y Finkel A Cortot R Modigliani P Laurent-Puig C Gower-Rousseau J Macry JF Colombel M Sahbatou G Thomas 2001 Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease Nature 411-599
28. AJ Grant PF Lalor M Salmi S Jalkanen DH Adams 2002 Homing of mucosal lymphocytes to the liver in the pathogenesis of hepatic complications of inflammatory bowel disease Lancet 359-150
29. Vierling J (1998) Aetiopathogenesis of primary sclerosing cholangitis. In: Manns P, Stieihl A, Wiesner R (eds) Primary sclerosing cholangitis. Kluwer Academic, London, p 9
30. CA O'Mahony JM Vierling 2006 Etiopathogenesis of primary sclerosing cholangitis Semin Liver Dis 26 3
31. Eksteen B, Mora JR, Haughton EL, Henderson NC, Lee-Turner L, Villablanca EJ, Curbishley SM, Aspinall AI, von Andrian UH, Adams DH (2009) Gut homing receptors on CD8 T-cells ARE retinoic acid dependent and not maintained by Liver dendritic or stellate cells. Gastroenterology (in press)
32. B Eksteen A Miles SM Curbishley C Tselepis AJ Grant LS Walker DH Adams 2006 Epithelial inflammation is associated with CCL28 production and the recruitment of regulatory T cells expressing CCR10 J Immunol 177 593-603
33. B Eksteen AJ Grant A Miles SM Curbishley PF Lalor SG Hubscher M Briskin M Salmon DH Adams 2004 Hepatic endothelial CCL25 mediates the recruitment of CCR9+ gut-homing lymphocytes to the liver in primary sclerosing cholangitis J Exp Med 200 1511
34. AJ Grant S Goddard J Ahmed-Choudhury G Reynolds DG Jackson M Briskin L Wu SG Hubscher DH Adams 2002 Hepatic expression of secondary lymphoid chemokine (CCL21) promotes the development of portal-associated lymphoid tissue in chronic inflammatory liver disease Am J Pathol 160 1445-1455
35. AJ Grant PF Lalor SG Hubscher M Briskin DH Adams 2001 MAdCAM-1 expressed in chronic inflammatory liver disease supports mucosal lymphocyte adhesion to hepatic endothelium (MAdCAM-1 in chronic inflammatory liver disease) Hepatology 33 1065
36. R Kurkijarvi DH Adams R Leino T Mottonen S Jalkanen M Salmi 1998 Circulating form of human vascular adhesion protein-1 (VAP-1): increased serum levels in inflammatory liver diseases J Immunol 161 1549-1557
37. P Fickert T Moustafa M Trauner 2007 Primary sclerosing cholangitis-the arteriosclerosis of the bile duct? Lipids Health Dis 6
38. O Rosmorduc B Hermelin PY Boelle RE Poupon R Poupon O Chazouilleres 2004 ABCB4 gene mutations and primary sclerosing cholangitis Gastroenterology 126 1220
39. C Pauli-Magnus R Kerb K Fattinger T Lang B Anwald GA Kullak-Ublick U Beuers PJ Meier 2004 BSEP and MDR3 haplotype structure in healthy Caucasians, primary biliary cirrhosis and primary sclerosing cholangitis Hepatology 39 779
40. A Stiehl G Rudolph P Sauer L Theilmann 1995 Biliary secretion of bile acids and lipids in primary sclerosing cholangitis. Influence of cholestasis and effect of ursodeoxycholic acid treatment J Hepatol 23 283-289
41. JM Vierling 2001 Animal models for primary sclerosing cholangitis Best Pract Res Clin Gastroenterol 15 591
42. CH Hobson TJ Butt DM Ferry J Hunter VS Chadwick MF Broom 1988 Enterohepatic circulation of bacterial chemotactic peptide in rats with experimental colitis Gastroenterology 94 1006-1013
43. RP Anderson TJ Butt VS Chadwick 1992 Hepatobiliary excretion of bacterial formyl-methionyl peptides in rat. Structure activity studies Dig Dis Sci 37 248
44. CH Hobson EC Roberts MF Broom DM Mellor RM Sherriff VS Chadwick 1990 Radio-immunoassay for formyl methionyl leucyl phenylalanine. I. Development and application to assessment of chemotactic peptide production by enteric bacteria J Gastroenterol Hepatol 5 32
45. S Yamada M Ishii N Kisara R Nagatomi T Toyota 1999 Macrophages are essential for lymphocyte infiltration in formyl peptide-induced cholangitis in rat liver Liver 19 253
46. S Yamada M Ishii LS Liang T Yamamoto T Toyota 1994 Small duct cholangitis induced by N-formyl L-methionine L-leucine L-tyrosine in rats J Gastroenterol 29 631
47. SN Lichtman RB Sartor J Keku JH Schwab 1990 Hepatic inflammation in rats with experimental small intestinal bacterial overgrowth Gastroenterology 98 414-423
48. SN Lichtman J Keku JH Schwab RB Sartor 1991 Hepatic injury associated with small bowel bacterial overgrowth in rats is prevented by metronidazole and tetracycline Gastroenterology 100 513-519
49. SN Lichtman EE Okoruwa J Keku JH Schwab RB Sartor 1992 Degradation of endogenous bacterial cell wall polymers by the muralytic enzyme mutanolysin prevents hepatobiliary injury in genetically susceptible rats with experimental intestinal bacterial overgrowth J Clin Invest 90 1313
50. E Bjornsson A Cederborg A Akvist M Simren PO Stotzer I Bjarnason 2005 Intestinal permeability and bacterial growth of the small bowel in patients with primary sclerosing cholangitis Scand J Gastroenterol 40 1090
51. JR Scott AE Fox-Robichaud 2002 Hepatic leukocyte recruitment in a model of acute colitis Am J Physiol Gastrointest Liver Physiol 283 G561 G566
52. E Mazzon D Puzzolo AP Caputi S Cuzzocrea 2002 Role of IL-10 in hepatocyte tight junction alteration in mouse model of experimental colitis Mol Med 8 353-366
53. L Lora E Mazzon D Martines W Fries M Muraca A Martin A d'Odorico R Naccarato S Citi 1997 Hepatocyte tight-junctional permeability is increased in rat experimental colitis Gastroenterology 113 1347
54. Y Numata S Tazuma T Nishioka Y Ueno K Chayama 2004 Immune response in mouse experimental cholangitis associated with colitis induced by dextran sulfate sodium J Gastroenterol Hepatol 19 910
55. Y Numata S Tazuma Y Ueno T Nishioka H Hyogo K Chayama 2005 Therapeutic effect of repeated natural killer T cell stimulation in mouse cholangitis complicated by colitis Dig Dis Sci 50 1844-1851
56. PG Blanco MM Zaman O Junaidi S Sheth RK Yantiss IA Nasser SD Freedman 2004 Induction of colitis in cftr-/- mice results in bile duct injury Am J Physiol Gastrointest Liver Physiol 287 G491
57. J Rivera-Nieves J Ho G Bamias N Ivashkina K Ley M Oppermann F Cominelli 2006 Antibody blockade of CCL25/CCR9 ameliorates early but not late chronic murine ileitis Gastroenterology 131 1518
58. P Fickert A Fuchsbichler M Wagner G Zollner A Kaser H Tilg R Krause F Lammert C Langner K Zatloukal HU Marschall H Denk M Trauner 2004 Regurgitation of bile acids from leaky bile ducts causes sclerosing cholangitis in Mdr2 (Abcb4) knockout mice Gastroenterology 127-261
59. TJ Weismuller J Wedemeyer S Kubicka CP Strassburg MP Manns 2008 The challenges in primary sclerosing cholangitis-aetiopathogenesis, autoimmunity, management and malignancy J Hepatol 48 Suppl 1 S38 S57
60. A Bergquist SM Montgomery S Bahmanyar R Olsson A Danielsson S Lindgren H Prytz R Hultcrantz LA Loof H Sandberg-Gertzen S Almer J Askling A Ehlin A Ekbom 2008 Increased risk of primary sclerosing cholangitis and ulcerative colitis in first-degree relatives of patients with primary sclerosing cholangitis Clin Gastroenterol Hepatol 6 939
61. E Schrumpf O Fausa O Forre JH Dobloug S Ritland E Thorsby 1982 HLA antigens and immunoregulatory T cells in ulcerative colitis associated with hepatobiliary disease Scand J Gastroenterol 17 187-191 (Pubitemid 12185520)
62. RW Chapman Z Varghese R Gaul G Patel N Kokinon S Sherlock 1983 Association of primary sclerosing cholangitis with HLA-B8 Gut 24 38
63. TM Neri GM Cavestro P Seghini PF Zanelli A Zanetti M Savi M Podda M Zuin M Colombo A Floreani F Rosina G Bianchi Porro M Strazzabosco L Okolicsanyi 2003 Novel association of HLA-haplotypes with primary sclerosing cholangitis (PSC) in a southern European population Dig Liver Dis 35 571
64. PL Bittencourt SA Palacios EL Cancado FJ Carrilho G Porta J Kalil AC Goldberg 2002 Susceptibility to primary sclerosing cholangitis in Brazil is associated with HLA-DRB1 13 but not with tumour necrosis factor alpha-308 promoter polymorphism Gut 51 609
65. GP Jeffrey WD Reed BH Laurence KB Shilkin 1990 Primary sclerosing cholangitis: clinical and immunopathological review of 21 cases J Gastroenterol Hepatol 5 135
66. MH Leidenius SA Koskimies IH Kellokumpu KA Hockerstedt 1995 HLA antigens in ulcerative colitis and primary sclerosing cholangitis APMIS 103 519-524
67. EJ Prochazka PI Terasaki MS Park LI Goldstein RW Busuttil 1990 Association of primary sclerosing cholangitis with HLA-DRw52a N Engl J Med 322 1842-1844
68. MS Park 1991 Inability to attribute susceptibility to primary sclerosing cholangitis to specific amino acid positions of the HLA-DRw52a allele N Engl J Med 325 1251-1252
69. JM Farrant DG Doherty PT Donaldson RW Vaughan KM Hayllar KI Welsh AL Eddleston R Williams 1992 Amino acid substitutions at position 38 of the DR beta polypeptide confer susceptibility to and protection from primary sclerosing cholangitis Hepatology 16 390
70. A Spurkland S Saarinen KM Boberg S Mitchell U Broome L Caballeria E Ciusani R Chapman G Ercilla O Fausa I Knutsen A Pares F Rosina O Olerup E Thorsby E Schrumpf 1999 HLA class II haplotypes in primary sclerosing cholangitis patients from five European populations Tissue Antigens 53 459
71. SI Khakoo M Carrington 2006 KIR and disease: a model system or system of models? Immunol Rev 214-186
72. GW Nelson MP Martin D Gladman J Wade J Trowsdale M Carrington 2004 Cutting edge: heterozygote advantage in autoimmune disease: hierarchy of protection/susceptibility conferred by HLA and killer Ig-like receptor combinations in psoriatic arthritis J Immunol 173 4273-4276
73. MP Martin X Gao JH Lee GW Nelson R Detels JJ Goedert S Buchbinder K Hoots D Vlahov J Trowsdale M Wilson SJ O'Brien M Carrington 2002 Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS Nat Genet 31 429-434
74. A Lopez-Vazquez L Rodrigo J Martinez-Borra R Perez M Rodriguez JL Fdez-Morera D Fuentes S Rodriguez-Rodero S Gonzaez C Lopez-Larrea 2005 Protective effect of the HLA-Bw4I80 epitope and the killer cell immunoglobulin-like receptor 3DS1 gene against the development of hepatocellular carcinoma in patients with hepatitis C virus infection J Infect Dis 192-162
75. SI Khakoo CL Thio MP Martin CR Brooks X Gao J Astemborski J Cheng JJ Goedert D Vlahov M Hilgartner S Cox AM Little GJ Alexander ME Cramp SJ O'Brien WM Rosenberg DL Thomas M Carrington 2004 HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection Science 305-872
76. TH Karlsen KM Boberg M Olsson JY Sun D Senitzer A Bergquist E Schrumpf E Thorsby BA Lie 2007 Particular genetic variants of ligands for natural killer cell receptors may contribute to the HLA associated risk of primary sclerosing cholangitis J Hepatol 46 899
77. S Norris E Kondeatis R Collins J Satsangi M Clare R Chapman H Stephens P Harrison R Vaughan P Donaldson 2001 Mapping MHC-encoded susceptibility and resistance in primary sclerosing cholangitis: the role of MICA polymorphism Gastroenterology 120 1475
78. K Wiencke A Spurkland E Schrumpf KM Boberg 2001 Primary sclerosing cholangitis is associated to an extended B8-DR3 haplotype including particular MICA and MICB alleles Hepatology 34 625-630
79. K Wiencke TH Karlsen KM Boberg E Thorsby E Schrumpf BA Lie A Spurkland 2007 Primary sclerosing cholangitis is associated with extended HLA-DR3 and HLA-DR6 haplotypes Tissue Antigens 69 161
80. TH Karlsen KM Boberg M Vatn A Bergquist J Hampe E Schrumpf E Thorsby S Schreiber BA Lie 2007 Different HLA class II associations in ulcerative colitis patients with and without primary sclerosing cholangitis Genes Immun 8 275
81. P Gaj A Habior M Mikula J Ostrowski 2008 Lack of evidence for association of primary sclerosing cholangitis and primary biliary cirrhosis with risk alleles for Crohn's disease in Polish patients BMC Med Genet 9
82. TH Karlsen J Hampe K Wiencke E Schrumpf E Thorsby BA Lie U Broome S Schreiber KM Boberg 2007 Genetic polymorphisms associated with inflammatory bowel disease do not confer risk for primary sclerosing cholangitis Am J Gastroenterol 102-115
83. X Yang SN Cullen JH Li RW Chapman DP Jewell 2004 Susceptibility to primary sclerosing cholangitis is associated with polymorphisms of intercellular adhesion molecule-1 J Hepatol 40 375
84. CL Bowlus TH Karlsen U Broome E Thorsby M Vatn E Schrumpf BA Lie KM Boberg 2006 Analysis of MAdCAM-1 and ICAM-1 polymorphisms in 365 Scandinavian patients with primary sclerosing cholangitis J Hepatol 45 704
85. P Donaldson K Agarwal S Saarinen C Strassbourg A Craggs P Harrison M Hudson U Broome M Manns 2000 Investigation of CCR5 Delta 32 deletion and FAS/APO-1 (CD95) single nucleotide polymorphisms in primary sclerosing cholangitis (PSC) Hepatology 32 174A
86. J Satsangi J Simmons S Marshall S Mitchell R Chapman K Welsh D Jewell 2000 CCR5 Delta 32 polymorphism in inflammatory bowel disease: further association with ulcerative colitis and with primary sclerosing cholangitis Gastroenterology 118
87. R Eri JR Jonsson N Pandeya DM Purdie AD Clouston N Martin D Duffy EE Powell J Fawcett TH Florin GL Radford-Smith 2004 CCR5-Delta32 mutation is strongly associated with primary sclerosing cholangitis Genes Immun 5 444
88. L Henckaerts J Fevery W Van Steenbergen C Verslype P Yap F Nevens T Roskams L Libbrecht P Rutgeerts S Vermeire 2006 CC-type chemokine receptor 5-Delta32 mutation protects against primary sclerosing cholangitis Inflamm Bowel Dis 12 272
89. E Melum TH Karlsen U Broome E Thorsby E Schrumpf KM Boberg BA Lie 2006 The 32-base pair deletion of the chemokine receptor 5 gene (CCR5-Delta32) is not associated with primary sclerosing cholangitis in 363 Scandinavian patients Tissue Antigens 68 78
90. E Seki DA Brenner 2008 Toll-like receptors and adaptor molecules in liver disease: update Hepatology 48 322
91. A Karrar U Broome T Sodergren M Jaksch A Bergquist M Bjornstedt S Sumitran-Holgersson 2007 Biliary epithelial cell antibodies link adaptive and innate immune responses in primary sclerosing cholangitis Gastroenterology 132 1504
92. RG Cameron LM Blendis MG Neuman 2001 Accumulation of macrophages in primary sclerosing cholangitis Clin Biochem 34 195
93. J Pohl A Ring W Stremmel A Stiehl 2006 The role of dominant stenoses in bacterial infections of bile ducts in primary sclerosing cholangitis Eur J Gastroenterol Hepatol 18 69
94. CY Ponsioen J Defoer FJ Ten Kate GJ Weverling GN Tytgat Y Pannekoek PM Wertheim-Dillen 2002 A survey of infectious agents as risk factors for primary sclerosing cholangitis: are Chlamydia species involved? Eur J Gastroenterol Hepatol 14 641
95. AM Krasinskas Y Yao P Randhawa MP Dore AR Sepulveda 2007 Helicobacter pylori may play a contributory role in the pathogenesis of primary sclerosing cholangitis Dig Dis Sci 52 2265
96. SY Boomkens S de Rave RG Pot HF Egberink LC Penning J Rothuizen PE Zondervan JG Kusters 2005 The role of Helicobacter spp. in the pathogenesis of primary biliary cirrhosis and primary sclerosing cholangitis FEMS Immunol Med Microbiol 44 221
97. RW Leong JJ Sung 2002 Review article: Helicobacter species and hepatobiliary diseases Aliment Pharmacol Ther 16 1037
98. X Bo U Broome M Remberger S Sumitran-Holgersson 2001 Tumour necrosis factor alpha impairs function of liver derived T lymphocytes and natural killer cells in patients with primary sclerosing cholangitis Gut 49 131
99. TL Whiteside S Lasky L Si DH Van Thiel 1985 Immunologic analysis of mononuclear cells in liver tissues and blood of patients with primary sclerosing cholangitis Hepatology 5 468
100. L Si TL Whiteside RR Schade TE Starzl DH Van Thiel 1984 T-lymphocyte subsets in liver tissues of patients with primary biliary cirrhosis (PBC), patients with primary sclerosing cholangitis (PSC), and normal controls J Clin Immunol 4 262
101. JA Snook RW Chapman GK Sachdev A Heryet PM Kelly KA Fleming DP Jewell 1989 Peripheral blood and portal tract lymphocyte populations in primary sclerosing cholangitis J Hepatol 9 36
102. E Hashimoto KD Lindor HA Homburger ER Dickson AJ Czaja RH Wiesner J Ludwig 1993 Immunohistochemical characterization of hepatic lymphocytes in primary biliary cirrhosis in comparison with primary sclerosing cholangitis and autoimmune chronic active hepatitis Mayo Clin Proc 68 1049-1055
103. CS Probert AD Christ LJ Saubermann JR Turner A Chott D Carr-Locke SP Balk RS Blumberg 1997 Analysis of human common bile duct-associated T cells: evidence for oligoclonality, T cell clonal persistence, and epithelial cell recognition J Immunol 158 1941-1948
104. U Broome J Grunewald A Scheynius O Olerup R Hultcrantz 1997 Preferential V beta3 usage by hepatic T lymphocytes in patients with primary sclerosing cholangitis J Hepatol 26 527
105. EB Martins AK Graham RW Chapman KA Fleming 1996 Elevation of gamma delta T lymphocytes in peripheral blood and livers of patients with primary sclerosing cholangitis and other autoimmune liver diseases Hepatology 23 988-993
106. L Wen M Peakman G Mieli-Vergani D Vergani 1992 Elevation of activated gamma delta T cell receptor bearing T lymphocytes in patients with autoimmune chronic liver disease Clin Exp Immunol 89 78 82
107. KJ Hillan KE Hagler RN MacSween AM Ryan ME Renz HH Chiu RK Ferrier GL Bird AP Dhillon LD Ferrell S Fong 1999 Expression of the mucosal vascular addressin, MAdCAM-1, in inflammatory liver disease Liver 19 509
108. KF Yoong G McNab SG Hubscher DH Adams 1998 Vascular adhesion protein-1 and ICAM-1 support the adhesion of tumor-infiltrating lymphocytes to tumor endothelium in human hepatocellular carcinoma J Immunol 160 3978-3988
109. G McNab JL Reeves M Salmi S Hubscher S Jalkanen DH Adams 1996 Vascular adhesion protein 1 mediates binding of T cells to human hepatic endothelium Gastroenterology 110-522
110. B Eksteen AE Miles AJ Grant DH Adams 2004 Lymphocyte homing in the pathogenesis of extra-intestinal manifestations of inflammatory bowel disease Clin Med 4 173-180
111. S Jalkanen M Salmi 2008 VAP-1 and CD73, endothelial cell surface enzymes in leukocyte extravasation Arterioscler Thromb Vasc Biol 28 18
112. M Salmi S Tohka EL Berg EC Butcher S Jalkanen 1997 Vascular adhesion protein 1 (VAP-1) mediates lymphocyte subtype-specific, selectin-independent recognition of vascular endothelium in human lymph nodes J Exp Med 186-589
113. PF Lalor S Edwards G McNab M Salmi S Jalkanen DH Adams 2002 Vascular adhesion protein-1 mediates adhesion and transmigration of lymphocytes on human hepatic endothelial cells J Immunol 169 983-992
114. PF Lalor PJ Sun CJ Weston A Martin-Santos MJ Wakelam DH Adams 2007 Activation of vascular adhesion protein-1 on liver endothelium results in an NF-kappaB-dependent increase in lymphocyte adhesion Hepatology 45 465
115. CS Bonder MU Norman MG Swain LD Zbytnuik J Yamanouchi P Santamaria M Ajuebor M Salmi S Jalkanen P Kubes 2005 Rules of recruitment for Th1 and Th2 lymphocytes in inflamed liver: a role for alpha-4 integrin and vascular adhesion protein-1 Immunity 23 153
116. E Patsenker Y Popov F Stickel A Jonczyk SL Goodman D Schuppan 2008 Inhibition of integrin alphavbeta6 on cholangiocytes blocks transforming growth factor-beta activation and retards biliary fibrosis progression Gastroenterology 135-660
117. C Silvain A Zeevi S Saidman RJ Duquesnoy DH Van Thiel 1995 Phenotypic and functional characteristics of colonic lymphocytes isolated from patients with primary sclerosing cholangitis and inflammatory bowel disease Hepatogastroenterology 42 250-258
118. U Broome R Hultcrantz AK Lefvert Q Yi 1998 Cytokine production from colonic T cells in patients with ulcerative colitis with and without primary sclerosing cholangitis Dis Colon Rectum 41 1543
119. CA Aoki K Dawson TP Kenny ME Gershwin CL Bowlus 2006 Gene expression by PBMC in primary sclerosing cholangitis: evidence for dysregulation of immune mediated genes Clin Dev Immunol 13 265
120. C Spirli L Fabris E Duner R Fiorotto G Ballardini T Roskams NF Larusso A Sonzogni L Okolicsanyi M Strazzabosco 2003 Cytokine-stimulated nitric oxide production inhibits adenylyl cyclase and cAMP-dependent secretion in cholangiocytes Gastroenterology 124-737
121. MK Washington 2007 Autoimmune liver disease: overlap and outliers Mod Pathol 20 Suppl 1 S15
122. C Schwarze B Terjung P Lilienweiss U Beuers V Herzog T Sauerbruch U Spengler 2003 IgA class antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis and autoimmune hepatitis Clin Exp Immunol 133-283
123. CS Pokorny ID Norton GW McCaughan WS Selby 1994 Anti-neutrophil cytoplasmic antibody: a prognostic indicator in primary sclerosing cholangitis J Gastroenterol Hepatol 9 40
124. D Bansi R Chapman K Fleming 1996 Antineutrophil cytoplasmic antibodies in chronic liver diseases: prevalence, titre, specificity and IgG subclass J Hepatol 24 581
125. T Orth R Kellner O Diekmann J Faust KH Meyer zum Buschenfelde WJ Mayet 1998 Identification and characterization of autoantibodies against catalase and alpha-enolase in patients with primary sclerosing cholangitis Clin Exp Immunol 112-507
126. H Schultz J Weiss SF Carroll WL Gross 2001 The endotoxin-binding bactericidal/permeability-increasing protein (BPI): a target antigen of autoantibodies J Leukoc Biol 69 505-512
127. MP Stoffel E Csernok C Herzberg T Johnson SF Carroll WL Gross 1996 Anti-neutrophil cytoplasmic antibodies (ANCA) directed against bactericidal/permeability increasing protein (BPI): a new seromarker for inflammatory bowel disease and associated disorders Clin Exp Immunol 104 54
128. B Terjung J Soehne HJ Worman T Sauerbruch U Spengler 2006 Molecular mimicry between target antigen of ANCA and microbial protein FtsZ in autoimmune liver disorders Hepatology 44 229A 229A
129. B Terjung M Muennich J Gottwein J Soehne HJ Worman T Sauerbruch U Spengler 2005 Identification of myeloid-specific tubulin-beta isotype 5 as target antigen of antineutrophil cytoplasmic antibodies in autoimmune liver disorders Hepatology 42 288A 288A
130. B Terjung U Spengler 2009 Atypical p-ANCA in PSC and AIH: a hint toward a "leaky gut" Clin Rev Allergy Immunol 36 40 51
131. B Xu U Broome BG Ericzon S Sumitran-Holgersson 2002 High frequency of autoantibodies in patients with primary sclerosing cholangitis that bind biliary epithelial cells and induce expression of CD44 and production of interleukin 6 Gut 51 120
132. SN Lichtman J Keku RL Clark JH Schwab RB Sartor 1991 Biliary tract disease in rats with experimental small bowel bacterial overgrowth Hepatology 13 766